The New Medication Options For Treating Mental Illnesses & Addictive Disorders: A Briefing For Clinical Executives
Free Executive Web Briefing Courtesy Of Genoa Healthcare
June 29, 2021 | 1:00 p.m. Eastern
What’s on the horizon in 2021 and beyond for treatment options for mental illness and substance use disorder? Join Stephanie Kornechuk, PharmD, Genoa Healthcare’s Senior Vice President of Procurement, for an up-to-the-minute briefing on the new and upcoming treatment options for major depressive disorder, schizophrenia, bipolar disorder, and other forms of illness. She will provide an overview of newly-approved medications and medications pending approval in the pipeline. Dr. Kornechuk will also discuss pending policy changes that may improve accessibility to cutting edge medications for opioid use disorder.
Learning Objectives:
- Review 2020 drug approvals and the recent pace of FDA approvals
- Explore new behavioral health drugs approved in 2021
- Look ahead to coming drug trends
- Provide perspectives on recent COVID-19 vaccine developments
Featured Speakers
-
Stephanie Kornechuk, PharmD, Senior Vice President of Procurement, Genoa HealthcareStephanie Kornechuk, PharmD, is the chief procurement officer for Genoa Healthcare. She joined the organization 2003 as a pharmacy manager in Puyallup, Washington, and has held several leadership roles. Prior to Genoa, Kornechuk was a hospital pharmacist for St. Joseph Medical Center in Tacoma, Washington, and a long-term care pharmacist for Northwood Clinical Pharmacy and Shoppers Drug Mart in Halifax, Nova Scotia, Canada. She holds a Bachelor of Science degree in Pharmacy from Dalhousie University in Halifax, Nova Scotia, and a Doctor of Pharmacy degree from the University of Washington in Seattle.
Registration for this executive web briefing has been provided at no charge courtesy of Genoa Healthcare.
Unable to attend? Still register! At the conclusion of the event, all registrants will receive a recorded copy of the executive web briefing and presentation slides.